| Product Name | Ramatroban |
|---|---|
| CAS | 116649-85-5 |
| Formula | C21H21FN2O4S |
| MW | 416.47 |
| Appearance | White to off-white powder |
| Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
|---|---|---|---|---|
| 10 mg | In-stock | ¥550.00 | Visible after login | |
| 25 mg | In-stock | ¥880.00 | Visible after login | |
| 50 mg | 3-5days | ¥1408.00 | Visible after login |
| Product Name | Ramatroban |
|---|---|
| CAS | 116649-85-5 |
| Formula | C21H21FN2O4S |
| MW | 416.47 |
| Appearance | White to off-white powder |
| Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Ramatroban is a novel, potent and selective antagonist of thromboxane A2 (TxA2) with an IC50 of 14 nM. It also inhibits PGD2 binding, which antagonizes CRTH2 (IC50=113 nM). In addition to treating asthma, ramatroban is recommended for the treatment of coronary artery disease.